Literature DB >> 32826106

Theophylline toxicity: Successful management of a patient with distributive shock secondary to drug overdose.

V P Chandrasekaran1, Anand Parthasarathy2, Balaji Muruga2.   

Abstract

Presenting a case of acute theophylline and salbutamol overdose with distributive shock. Twenty one years old lady presented with history of consumption of 3 gram of theophylline and 40 mg of salbutamol. On admission she had altered sensorium with the systolic blood pressure of 60 mmHg, unrecordable diastolic blood pressure and heart rate of 147/min. Investigations revealed severe metabolic acidosis, hypokalemia, hypocalcemia which was managed by intravenous fluids, vasopressors, infusion of injection calcium gluconate and injection potassium chloride. As her hemodynamic status did not improve, she has been initiated on 1.5 mL/kg of lipid emulsion as bolus and then 0.5 mL/kg/h as infusion. Her hemodynamic status improved gradually and she was discharged in 24 h. Lipid emulsion had been used in local anesthetics and many tablet overdoses. In this patient timely administration of lipid emulsion resulted in early recovery of shock.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Lipid emulsion; Overdose; Poisoning; Theoasthalin; Theophylline; Toxicity

Mesh:

Substances:

Year:  2020        PMID: 32826106     DOI: 10.1016/j.ajem.2020.05.112

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  2 in total

1.  A Disposable Sensor Chip Using a Paste Electrode with Surface-Imprinted Graphite Particles for Rapid and Reagentless Monitoring of Theophylline.

Authors:  Tomoji Ohishi; Yasuo Yoshimi
Journal:  Molecules       Date:  2022-04-11       Impact factor: 4.927

2.  An Electrochemical Electrode to Detect Theophylline Based on Copper Oxide Nanoparticles Composited with Graphene Oxide.

Authors:  Vinoda B Patil; Shweta J Malode; Sumitra N Mangasuli; Suresh M Tuwar; Kunal Mondal; Nagaraj P Shetti
Journal:  Micromachines (Basel)       Date:  2022-07-23       Impact factor: 3.523

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.